BMEZ

NYSE BlackRock Health Sciences Term Trust Common Shares of Beneficial Interest
Nov 20, 2026 · 12:19 AM ET EOD Market Closed

$15.92 ↑ +0.00 (+0.00%) Trading Up from the previous close of $15.92, $0.77 below the day’s high of $16.69

YTD change
+5.78%
vs 20-day SMA
-7.75%
vs 200-day SMA
+3.17%

Price ranges

Previous day
$16.29 $16.84
open $16.54 close $16.42
-$0.12 (-0.73%)
Today
$15.88 $16.69
open $16.26 now $15.92
-$0.34 (-2.09%)
Past week
$16.29 $17.66
from $17.51 now $15.92
-$1.59 (-9.08%)
Past month
$16.29 $17.96
from $16.93 now $15.92
-$1.01 (-5.97%)
This year
$13.70 $17.96
from $15.05 now $15.92
+$0.87 (+5.78%)

Price & Performance

+2.08 (+15.03%) / 6M

$13.52$15.07$16.62$18.17May 19Aug 20Nov 19

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Poor
  • The stock is 48.6% away from all-time highs of $30.96
  • BMEZ is up 6% since the beginning of the year
  • BMEZ is up 9% over the past 12 months
  • BMEZ is down 6% over the past 1 month

BMEZ reads poor: price sits above one of the two key moving averages, the 12-month move is +8.8%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable N/A
EPS N/A
Earnings momentum N/A Quarterly EPS growth
Quarterly change N/A

Valuation

P/E ratio 10.41

Balance sheet & scale

IncomeN/A
RevenueN/A
CashN/A
DebtN/A
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNYSE
Sector Finance and Insurance
Sub Sector Funds, Trusts, and Other Financial Vehicles
Market cap N/A

Competitor comparison

TickerCompany PriceChange
GLD SPDR Gold Shares $335.18 -1.76%
GLDM SPDR Gold MiniShares Trust $72.34 -1.79%
OUNZ VanEck Merk Gold ETF $35.13 -1.73%
ACNDF CapitaLand India Trust $0.6902 -5.45%
AAAU Goldman Sachs Physical Gold ETF Shares $36.05 -1.74%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.